Cell type-specific activation of p38 MAPK in the brain regions of hypoxic preconditioned mice

Neurochemistry International

Volumn 51, Issue 8, 2007, Pages 459-466

  Bu, Xiangning ^a   Huang, Ping ^a   Qi, Zhifeng ^a   Zhang, Nan ^a   Han, Song ^a   Fang, Li ^b   Li, Junfa ^a  

^a Beijing Key Laboratory for Neural Regeneration and Repairing   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Brain; Hypoxic preconditioning (HPC); P38 mitogen activated protein kinases (p38 MAPK); Phosphorylation; Protein expression

Indexed keywords

CD11B ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN S 100; THREONINE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD11; ASTROCYTES; BIOLOGICAL MARKERS; BRAIN; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; HYPOXIA-ISCHEMIA, BRAIN; ISCHEMIC PRECONDITIONING; MALE; MICE; MICE, INBRED BALB C; MICROGLIA; NEUROFILAMENT PROTEINS; NEUROGLIA; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; S100 PROTEINS;

MUS;

EID: 34848895938     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.04.028     Document Type: Article

References (43)

1. Beyaert R., Cuenda A., Vanden Berghe W., Plaisance S., Lee J.C., Haegeman G., Cohen P., and Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15 (1996) 1914-1923
2. Bhat N.R., Zhang P., Lee J.C., and Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18 (1998) 1633-1641
3. Boje K.M., and Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587 (1992) 250-256
4. Bruer U., Weih M.K., Isaev N.K., Meisel A., Ruscher K., Bergk A., Trendelenburg G., Wiegand F., Victorov I.V., and Dirnagl U. Induction of tolerance in rat cortical neurons: hypoxic preconditioning. FEBS Lett. 414 (1997) 117-121
5. Da Silva J., Pierrat B., Mary J.L., and Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272 (1997) 28373-28380
6. Deak M., Clifton A.D., Lucocq L.M., and Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17 (1998) 4426-4441
7. Gao Y., Gao G., Long C., Han S., Zu P., Fang L., and Li J. Enhanced phosphorylation of cyclic AMP response element binding protein in the brain of mice following repetitive hypoxic exposure. Biochem. Biophys. Res. Commun. 340 (2006) 661-667
8. Gu Z., Jiang Q., and Zhang G. Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance. Neuroreport 12 (2001) 3487-3491
9. Hausenloy D.J., and Yellon D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc. Res. 70 (2006) 240-253
10. Ikeda R., Che X.F., Ushiyama M., Yamaguchi T., Okumura H., Nakajima Y., Takeda Y., Shibayama Y., Furukawa T., Yamamoto M., Haraguchi M., Sumizawa T., Yamada K., and Akiyama S. 2-Deoxy-d-ribose inhibits hypoxia-induced apoptosis by suppressing the phosphorylation of p38 MAPK. Biochem. Biophys. Res. Commun. 342 (2006) 280-285
11. Irving E.A., Barone F.C., Reith A.D., Hadingham S.J., and Parsons A.A. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res. Mol. Brain Res. 77 (2000) 65-75
12. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
13. Jones N.M., and Bergeron M. Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J. Neurochem. 89 (2004) 157-167
14. Jung Y.S., Jung Y.S., Kim M.Y., and Kim E. Identification of caspase-independent PKCε-JNK/p38 MAPK sigmaling module in response to metabolic inhibition in H9c2 Cells. Jpn. J. Physiol. 54 (2004) 23-29
15. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239 (1982) 57-69
16. Lee S.R., and Lo E.H. Interactions between p38 mitogen-activated protein kinase and caspase-3 in cerebral endothelial cell death after hypoxia-reoxygenation. Stroke 34 (2003) 2704-2709
17. Lennmyr F., Ericsson A., Gerwins P., Ahlstrom H., and Terent A. Increased brain injury and vascular leakage after pretreatment with p38-inhibitor SB203580 in transient ischemia. Acta Neurol. Scand. 108 (2003) 339-345
18. Li J., Niu C., Han S., Zu P., Li H., Xu Q., and Fang L. Identification of protein kinase C isoforms involved in cerebral hypoxic preconditioning of mice. Brain Res. 1060 (2005) 62-72
19. Li J., Yang C., Han S., Zu P., Wu J., Xu Q., and Fang L. Increased phosphorylation of neurogranin in the brain of hypoxic preconditioned mice. Neurosci. Lett. 391 (2006) 150-153
20. Long C., Gao Y., Gao G., Han S., Zu P., Fang L., and Li J. Decreased phosphorylation and protein expression of ERK1/2 in the brain of hypoxic preconditioned mice. Neurosci. Lett. 397 (2006) 307-312
21. Lonze B.E., and Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35 (2002) 605-623
22. Lu G.W., and Liu H.Y. Downregulation of nitric oxide in the brain of mice during their hypoxic preconditioning. J. Appl. Physiol. 91 (2001) 1193-1198
23. Marais E., Genade S., Huisamen B., Strijdom J.G., Moolman J.A., and Lochner A. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion. J. Mol. Cell Cardiol. 33 (2001) 769-778
24. Matsumoto K., Hashimoto S., Gon Y., Nakayama T., and Horie T. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. J. Allergy Clin. Immunol. 101 (1998) 825-831
25. Morikawa Y., Ueyama E., and Senba E. Fasting-induced activation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus. J. Neuroendocrinol. 16 (2004) 105-112
26. Niu C., Li J., Cui X., Han S., Zu P., Li H., and Xu Q. Changes in cPKC isoform-specific membrane translocation and protein expression in the brain of hypoxic preconditioned mice. Neurosci. Lett. 384 (2005) 1-6
27. Piao C.S., Che Y., Han P.L., and Lee J.K. Delayed and differential induction of p38 MAPK isoforms in microglia and astrocytes in the brain after transient global ischemia. Brain Res. Mol. Brain Res. 107 (2002) 137-144
28. Saurin A.T., Martin J.L., Heads R.J., Foley C., Mockridge J.W., Wright M.J., Wang Y., and Marber M.S. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J. 14 (2000) 2237-2246
29. Schiller M., Bohm M., Dennler S., Ehrchen J.M., and Mauviel A. Mitogen- and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated, c-fos gene expression in keratinocytes. Oncogene 25 (2006) 4449-4457
30. Schwartz M.W., Woods S.C., Porte Jr. D., Seeley R.J., and Baskin D.G. Central nervous system control of food intake. Nature 404 (2000) 661-671
31. Shamloo M., Rytter A., and Wieloch T. Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience 93 (1999) 81-88
32. Sugino T., Nozaki K., Takagi Y., Hattori I., Hashimoto N., Moriguchi T., and Nishida E. Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J. Neurosci. 20 (2000) 4506-4514
33. Sun X.C., Li W.B., Li Q.J., Zhang M., Xian X.H., Qi J., Jin R.L., and Li S.Q. Limb ischemic preconditioning induces brain ischemic tolerance via p38 MAPK. Brain Res. 1084 (2006) 165-174
34. Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., and Comb M.J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15 (1996) 4629-4642
35. Tsai B.M., Wang M., March K.L., Turrentine M.W., Brown J.W., and Meldrum D.R. Preconditioning: evolution of basic mechanisms to potential therapeutic strategies. Shock 21 (2004) 195-209
36. Ueyama E., Morikawa Y., Yasuda T., and Senba E. Attenuation of fasting-induced phosphorylation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus in response to refeeding. Neurosci. Lett. 371 (2004) 40-44
37. Vannucci S.J., and Hagberg H. Hypoxia-ischemia in the immature brain. J. Exp. Biol. 207 (2004) 3149-3154
38. Walton K.M., DiRocco R., Bartlett B.A., Koury E., Marcy V.R., Jarvis B., Schaefer E.M., and Bhat R.V. Activation of p38MAPK in microglia after ischemia. J. Neurochem. 70 (1998) 1764-1767
39. Wang M., Tsai B.M., Turrentine M.W., Mahomed Y., Brown J.W., and Meldrum D.R. p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart. Ann. Thorac. Surg. 80 (2005) 2235-2241
40. Whitmarsh A.J., Yang S.H., Su M.S., Sharrocks A.D., and Davis R.J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell Biol. 17 (1997) 2360-2371
41. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79 (1999) 143-180
42. Wu D.C., Ye W., Che X.M., and Yang G.Y. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J. Cereb. Blood Flow Metab. 20 (2000) 1320-1330
43. Zheng S., and Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol. Pharmacol. 65 (2004) 1172-1180